Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk
  2. Fu, Y. P.; Kohaar, I.; Rothman, N.; Earl, J.; Figueroa, J. D.; Ye, Y.; Malats, N.; Tang, W.; Liu, L.; Garcia-Closas, M.; Muchmore, B.; Chatterjee, N.; Tarway, M.; Kogevinas, M.; Porter-Gill, P.; Baris, D.; Mumy, A.; Albanes, D.; Purdue, M. P.; Hutchinson, A.; Carrato, A.; Tardon, A.; Serra, C.; Garcia-Closas, R.; Lloreta, J.; Johnson, A.; Schwenn, M.; Karagas, M. R.; Schned, A.; Diver, W. R.; Gapstur, S. M.; Thun, M. J.; Virtamo, J.; Chanock, S. J.; Fraumeni, J. F.; Silverman, D. T.; Wu, X. F.; Real, F. X.; Prokunina-Olsson, L.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2012, Mar; 109(13): 4974-4979.
  1. 2.   A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3
  2. Garcia-Closas, M.; Ye, Y. Q.; Rothman, N.; Figueroa, J. D.; Malats, N.; Dinney, C. P.; Chatterjee, N.; Prokunina-Olsson, L.; Wang, Z. M.; Lin, J.; Real, F. X.; Jacobs, K. B.; Baris, D.; Thun, M.; De Vivo, I.; Albanes, D.; Purdue, M. P.; Kogevinas, M.; Kamat, A. M.; Lerner, S. P.; Grossman, H. B.; Gu, J.; Pu, X.; Hutchinson, A.; Fu, Y. P.; Burdett, L.; Yeager, M.; Tang, W.; Tardon, A.; Serra, C.; Carrato, A.; Garcia-Closas, R.; Lloreta, J.; Johnson, A.; Schwenn, M.; Karagas, M. R.; Schned, A.; Andriole, G.; Grubb, R.; Black, A.; Jacobs, E. J.; Diver, W. R.; Gapstur, S. M.; Weinstein, S. J.; Virtamo, J.; Hunter, D. J.; Caporaso, N.; Landi, M. T.; Fraumeni, J. F.; Silverman, D. T.; Chanock, S. J.; Wu, X. F.
  3. Human Molecular Genetics. 2011, Nov; 20(21): 4282-4289.
  1. 3.   Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations
  2. Lengruber, R. B.; Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Baumann, J.; Santos, A. F.; Pathak, V. K.; Soares, M. A.
  3. Journal of Antimicrobial Chemotherapy. 2011, Apr; 66(4): 702-708.
  1. 4.   Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study
  2. Fletcher, O.; Johnson, N.; Orr, N.; Hosking, F. J.; Gibson, L. J.; Walker, K.; Zelenika, D.; Gut, I.; Heath, S.; Palles, C.; Coupl, B.; Broderick, P.; Schoemaker, M.; Jones, M.; Williamson, J.; Chilcott-Burns, S.; Tomczyk, K.; Simpson, G.; Jacobs, K. B.; Chanock, S. J.; Hunter, D. J.; Tomlinson, I. P.; Swerdlow, A.; Ashworth, A.; Ross, G.; Silva, I. D.; Lathrop, M.; Houlston, R. S.; Peto, J.
  3. Journal of the National Cancer Institute. 2011, Mar; 103(5): 425-435.
  1. 5.   A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
  2. Rothman, N.; Garcia-Closas, M.; Chatterjee, N.; Malats, N.; Wu, X. F.; Figueroa, J. D.; Real, F. X.; Van den Berg, D.; Matullo, G.; Baris, D.; Thun, M.; Kiemeney, L. A.; Vineis, P.; De Vivo, I.; Albanes, D.; Purdue, M. P.; Rafnar, T.; Hildebrandt, M. A. T.; Kiltie, A. E.; Cussenot, O.; Golka, K.; Kumar, R.; Taylor, J. A.; Mayordomo, J. I.; Jacobs, K. B.; Kogevinas, M.; Hutchinson, A.; Wang, Z. W.; Fu, Y. P.; Prokunina-Olsson, L.; Burdett, L.; Yeager, M.; Wheeler, W.; Tardon, A.; Serra, C.; Carrato, A.; Garcia-Closas, R.; Lloreta, J.; Johnson, A.; Schwenn, M.; Karagas, M. R.; Schned, A.; Andriole, G.; Grubb, R.; Black, A.; Jacobs, E. J.; Diver, W. R.; Gapstur, S. M.; Weinstein, S. J.; Virtamo, J.; Cortessis, V. K.; Gago-Dominguez, M.; Pike, M. C.; Stern, M. C.; Yuan, J. M.; Hunter, D. J.; McGrath, M.; Dinney, C. P.; Czerniak, B.; Chen, M.; Yang, H. S.; Vermeulen, S. H.; Aben, K. K.; Witjes, J. A.; Makkinje, R. R.; Sulem, P.; Besenbacher, S.; Stefansson, K.; Riboli, E.; Brennan, P.; Panico, S.; Navarro, C.; Allen, N. E.; Bueno-De-Mesquita, H. B.; Trichopoulos, D.; Caporaso, N.; Landi, M. T.; Canzian, F.; Ljungberg, B.; Tjonnel, A.; Clavel-Chapelon, F.; Bishop, D. T.; Teo, M. T. W.; Knowles, M. A.; Guarrera, S.; Polidoro, S.; Ricceri, F.; Sacerdote, C.; Allione, A.; Cancel-Tassin, G.; Selinski, S.; Hengstler, J. G.; Dietrich, H.; Fletcher, T.; Rudnai, P.; Gurzau, E.; Koppova, K.; Bolick, S. C. E.; Godfrey, A.; Xu, Z. L.; Sanz-Velez, J. I.; Garcia-Prats, M. D.; Sanchez, M.; Valdivia, G.; Porru, S.; Benhamou, S.; Hoover, R. N.; Fraumeni, J. F.; Silverman, D. T.; Chanock, S. J.
  3. Nature Genetics. 2010, Nov; 42(11): 978-U98.
  1. 6.   Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium
  2. Canzian, F.; Cox, D. G.; Setiawan, V. W.; Stram, D. O.; Ziegler, R. G.; Dossus, L.; Beckmann, L.; Blanche, H.; Barricarte, A.; Berg, C. D.; Bingham, S.; Buring, J.; Buys, S. S.; Calle, E. E.; Chanock, S. J.; Clavel-Chapelon, F.; DeLancey, J. O. L.; Diver, W. R.; Dorronsoro, M.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hunter, D. J.; Husing, A.; Isaacs, C.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Le Marchand, L.; Lund, E.; Overvad, K.; Panico, S.; Peeters, P. H. M.; Pollak, M.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Yeager, M.; Hoover, R. N.; Riboli, E.; Thomas, G.; Henderson, B. E.; Kaaks, R.; Feigelson, H. S.
  3. Human Molecular Genetics. 2010, Oct; 19(19): 3873-3884.
  1. 7.   Genome-Wide Association Studies of Cancer
  2. Stadler, Z. K.; Thom, P.; Robson, M. E.; Weitzel, J. N.; Kauff, N. D.; Hurley, K. E.; Devlin, V.; Gold, B.; Klein, R. J.; Offit, K.
  3. Journal of Clinical Oncology. 2010, Sep; 28(27): 4255-4267.
  1. 8.   Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases
  2. Young, L. R.; VanDyke, R.; Gulleman, P. M.; Inoue, Y.; Brown, K. K.; Schmidt, L. S.; Linehan, W. M.; Hajjar, F.; Kinder, B. W.; Trapnell, B. C.; Bissler, J. J.; Franz, D. N.; McCormack, F. X.
  3. Chest. 2010, Sep; 138(3): 674-681.
  1. 9.   A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
  2. Nikolenko, G. N.; Delviks-Frankenberry, K. A.; Pathak, V. K.
  3. Journal of Virology. 2010, May; 84(10): 5238-5249.
  1. 10.   Novel Breast Cancer Risk Alleles and Interaction with Ionizing Radiation among US Radiologic Technologists
  2. Bhatti, P.; Doody, M. M.; Rajaraman, P.; Alexander, B. H.; Yeager, M.; Hutchinson, A.; Burdette, L.; Thomas, G.; Hunter, D. J.; Simon, S. L.; Weinstock, R. M.; Rosenstein, M.; Stovall, M.; Preston, D. L.; Linet, M. S.; Hoover, R. N.; Chanock, S. J.; Sigurdson, A. J.
  3. Radiation Research. 2010, Feb; 173(2): 214-224.
  1. 11.   Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
  2. Ahmed, S.; Thomas, G.; Ghoussaini, M.; Healey, C. S.; Humphreys, M. K.; Platte, R.; Morrison, J.; Maranian, M.; Pooley, K. A.; Luben, R.; Eccles, D.; Evans, D. G.; Fletcher, O.; Johnson, N.; Silva, I. D.; Peto, J.; Stratton, M. R.; Rahman, N.
  3. Nature Genetics. 2009 41(5): 585-590.
  1. 12.   The 6q22.33 Locus and Breast Cancer Susceptibility
  2. Kirchhoff, T.; Chen, Z. Q.; Gold, B.; Pal, P.; Gaudet, M. M.; Kosarin, K.; Levine, D. A.; Gregersen, P.; Spencer, S.; Harlan, M.; Robson, M.; Klein, R. J.; Hudis, C. A.; Norton, L.; Dean, M.; Offit, K.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(9): 2468-2475.
  1. 13.   A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
  2. Thomas, G.; Jacobs, K. B.; Kraft, P.; Yeager, M.; Wacholder, S.; Cox, D. G.; Hankinson, S. E.; Hutchinson, A.; Wang, Z.; Yu, K.; Chatterjee, N.; Garcia-Closas, M.; Gonzalez-Bosquet, J.; Prokunina-Olsson, L.; Orr, N.; Willett, W. C.
  3. Nature Genetics. 2009 41(5): 579-584.
  1. 14.   Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  2. Jones, K. S.; Fugo, K.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Lisinski, I.; Cushman, S. W.; Jacobson, S.; Ruscetti, F. W.
  3. Journal of Virology. 2006, Sep; 80(17): 8291-8302.
  1. 15.   Transmembrane inhibitors of ABCG2, an ABC transporter that confers chemoresistance in cancer stem cells
  2. Tarasova, N. I.; Henrich, C. J.; Amadei, G.; Bokesch, H. R.; Dyba, M. A.; Tarasov, S. G.; McMahon, J. B.; Michejda, C. J.
  3. Clinical Cancer Research. 2005, DEC 15; 11(24, Part 2 Suppl. S): 9052S-9052S.
  1. 16.   Membrane TNF confers protection to acute mycobacterial infection
  2. Fremond, C.; Allie, N.; Dambuza, I.; Grivennikov, S. I.; Yeremeev, V.; Quesniaux, V. F. J.; Jacobs, M.; Ryffel, B.
  3. Respiratory Research. 2005, NOV 14; 6(Art. No 136):
  1. 17.   The case for selection at CCR5-Delta 32
  2. Sabeti, P. C.; Walsh, E.; Schaffner, S. F.; Varilly, P.; Fry, B.; Hutcheson, H. B.; Cullen, M.; Mikkelsen, T. S.; Roy, J.; Patterson, N.; Cooper, R.; Reich, D.; Altshuler, D.; O'Brien, S.; Lander, E. S.
  3. Plos Biology. 2005, NOV; 3(11): 1963-1969.
  1. 18.   Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics
  2. Oishi, S.; Karki, R. G.; Kang, S. U.; Wang, X. Z.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2005, FEB 10; 48(3): 764-772.
  1. 19.   Endogenous leukemia inhibitory factor attenuates endotoxin response
  2. Weber, M. A.; Schnyder-Candrian, S.; Schnyder, B.; Quesniaux, V.; Poli, V.; Stewart, C. L.; Ryffel, B.
  3. Laboratory Investigation. 2005, FEB; 85(2): 276-284.
  1. 20.   Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface resonance plasmon technology
  2. Lung, F. D. T.; Chang, C. W.; Chong, M. C.; Liou, C. C.; Li, P.; Peach, M. L.; Nicklaus, M. C.; Lou, B. S.; Roller, P. P.
  3. Peptide Science (Biopolymers). 2005 80(5): 628-635.
  1. 21.   Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis
  2. Julias, J. G.; Boyer, P. L.; McWilliams, M. J.; Alvord, W. G.; Hughes, S. H.
  3. Virology. 2004 322(1): 13-21.
  1. 22.   A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion
  2. Xu, H. Z.; Svarovskaia, E. S.; Barr, R.; Zhang, Y. J.; Khan, M. A.; Strebel, K.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(15): 5652-5657.
  1. 23.   Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2 ',3 '-dideoxy-3 '-thiacytidine
  2. Halvas, E. K.; Svarovskaia, E. S.; Freed, E. O.; Pathak, V. K.
  3. Journal of Virology. 2000 74(14): 6669-6674.
  1. 24.   Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids
  2. Sarafianos, S. G.; Das, K.; Clark, A. D.; Ding, J. P.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(18): 10027-10032.
  1. 25.   Genetic Definition of a Protein-Splicing Domain - Functional Mini-Inteins Support Structure Predictions and a Model For Intein Evolution
  2. Derbyshire, V.; Wood, D. W.; Wu, W.; Dansereau, J. T.; Dalgaard, J. Z.; Belfort, M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1997 94(21): 11466-11471.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel